UNC’s Institute of Global Health and Infectious Diseases Director Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The randomized phase 3 clinical trial … Read more

  Eli Lilly today released results of a clinical trial that found bamlanivimab, a monoclonal antibody, significantly reduced the risk of contracting COVID-19 among residents and staff of long-term care facilities. The Phase 3 trial was conducted in partnership with the NIH’s National Institute of Allergy and Infectious Diseases and the COVID-19 Prevention Network (CoVPN). … Read more

Human beings will continue to suffer from infectious diseases, some of them contagious. To fight a new disease, infectious disease physicians first work to determine the rules that govern the disease, its spread, and the gravity of the infection. Those rules then determine our prevention and treatment strategies, Institute Director Myron Cohen, MD, told his … Read more

The National Institutes of Health has awarded Myron Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and FHI 360 $9.2 million to support research through the new COVID Prevention Network (CoVPN). The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has formed the network to better … Read more

Four appointments in 2020 have expanded the Institute for Global Health and Infectious Diseases’ Leadership Team. The team’s members bring unique expertise, experience, and perspectives from across the University of North Carolina’s health science schools to set strategy and lead the growth of one of UNC’s preeminent research centers. “Since our founding in 2007, the … Read more

  Three Institute for Global Health and Infectious Diseases representatives joined the May 21 UNC Board of Trustees meeting to talk about COVID-19 and the university’s response to the pandemic. Institute Director Myron Cohen, MD, talked about how so many of our researchers have pivoted their work to COVID, working on the development of vaccine … Read more

  Large-scale study funded by NIAID and ViiV Healthcare halted early after cabotegravir, dosed every two months, shows higher efficacy than daily oral pill.   The decades-long search for a vaccine to prevent HIV reached a new milestone as results from HPTN 083, a global large-scale study, show that the long-acting drug cabotegravir (CAB LA) … Read more

Myron Cohen, MD, Yeargan-Bate Distinguished Professor of medicine, microbiology, and immunology and epidemiology and director of the Institute for Global Health and Infectious Diseases, and Wesley Fowler, MD, associate dean for medical alumni affairs and professor of obstetrics and gynecology,and have been inducted into the Order of the Golden Fleece, UNC’s oldest and most prestigious … Read more

  By Myron Cohen, MD Our UNC infectious diseases community, encompassing many disciplines, has responded remarkably to COVID-19. Our physicians have been deployed to patient care and to advise the University and health system’s leadership. Researchers are quickly pivoting their work to focus on COVID. Among the many who have responded quickly: David Wohl and … Read more